These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 27110701)

  • 1. Cytoreductive surgery and HIPEC offers similar outcomes in patients with rectal peritoneal metastases compared to colon cancer patients: a matched case control study.
    Simkens GA; van Oudheusden TR; Braam HJ; Wiezer MJ; Nienhuijs SW; Rutten HJ; van Ramshorst B; de Hingh IH
    J Surg Oncol; 2016 Apr; 113(5):548-53. PubMed ID: 27110701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perioperative and Oncological Outcomes of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Metastasis of Rectal Origin.
    Benvenisti H; Shiber M; Assaf D; Shovman Y; Laks S; Elbaz N; Mor E; Zippel D; Nissan A; Ben-Yaacov A; Adileh M
    J Gastrointest Surg; 2023 Nov; 27(11):2506-2514. PubMed ID: 37726508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival and quality of life following cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis of colonic origin.
    Hill AR; McQuellon RP; Russell GB; Shen P; Stewart JH; Levine EA
    Ann Surg Oncol; 2011 Dec; 18(13):3673-9. PubMed ID: 21674272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Invited commentary: Extremely high peritoneal cancer index in colorectal peritoneal metastases demonstrates safety and overall survival benefit in selected patients undergoing cytoreductive surgery and heated intraperitoneal chemotherapy.
    Pocard M
    World J Surg; 2024 Apr; 48(4):879-880. PubMed ID: 38447984
    [No Abstract]   [Full Text] [Related]  

  • 5. Pelvic exenterations combined with cytoreductions for T4 rectal cancers with peritoneal metastasis: a safety analysis.
    Kazi M; Raghavan S; Desouza A; Saklani A
    ANZ J Surg; 2024 Apr; 94(4):702-707. PubMed ID: 38012077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neoadjuvant therapy, cytoreductive surgery and HIPEC in locally advanced colon cancer: Are we ready for a change in approach?
    Arjona-Sánchez A
    Cir Esp (Engl Ed); 2024 May; 102(5):241-242. PubMed ID: 38224769
    [No Abstract]   [Full Text] [Related]  

  • 7. Colon and rectal cancer survival in seven high-income countries 2010-2014: variation by age and stage at diagnosis (the ICBP SURVMARK-2 project).
    Araghi M; Arnold M; Rutherford MJ; Guren MG; Cabasag CJ; Bardot A; Ferlay J; Tervonen H; Shack L; Woods RR; Saint-Jacques N; De P; McClure C; Engholm G; Gavin AT; Morgan E; Walsh PM; Jackson C; Porter G; Møller B; Bucher O; Eden M; O'Connell DL; Bray F; Soerjomataram I
    Gut; 2021 Jan; 70(1):114-126. PubMed ID: 32482683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laparoscopic peritonectomy with or without rectal resection for peritoneal metastases of colon cancer involving the pouch of Douglas: a video vignette.
    Kang SJ; Shin HW; Seo AN; Park SY
    Colorectal Dis; 2024 Mar; 26(3):572-573. PubMed ID: 38225793
    [No Abstract]   [Full Text] [Related]  

  • 9. HIPECT4 Trial-the Devil Is in the Details! Is Prophylactic HIPEC and Cytoreduction the New Standard of Care for T4 Colorectal Cancer?
    Ballal DS; Saklani AP
    Indian J Surg Oncol; 2024 Jun; 15(2):302-303. PubMed ID: 38741653
    [No Abstract]   [Full Text] [Related]  

  • 10. What made hyperthermic intraperitoneal chemotherapy an effective curative treatment for peritoneal surface malignancy: A 25-year experience with 1,125 procedures.
    Passot G; Vaudoyer D; Villeneuve L; Kepenekian V; Beaujard AC; Bakrin N; Cotte E; Gilly FN; Glehen O
    J Surg Oncol; 2016 Jun; 113(7):796-803. PubMed ID: 27110915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The 2022 PSOGI International Consensus on HIPEC Regimens for Peritoneal Malignancies: HIPEC Technologies.
    Van der Speeten K; Kusamura S; Villeneuve L; Piso P; Verwaal VJ; González-Moreno S; Glehen O
    Ann Surg Oncol; 2024 Jul; ():. PubMed ID: 39037523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy with Intra-Operative Radiotherapy for Patients with Locally Advanced or Locally Recurrent Rectal Cancer and Peritoneal Metastases.
    van de Vlasakker VCJ; van den Heuvel TBM; Rijken A; Nienhuijs SW; Ketelaers SHJ; Verrijssen AE; Rutten HJ; Nieuwenhuijzen GAP; Burger JWA; de Hingh IHJT
    Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765814
    [No Abstract]   [Full Text] [Related]  

  • 13. Hyperthermic intraperitoneal chemotherapy and colorectal cancer: From physiology to surgery.
    Ammerata G; Filippo R; Laface C; Memeo R; Solaini L; Cavaliere D; Navarra G; Ranieri G; Currò G; Ammendola M
    World J Clin Cases; 2022 Oct; 10(30):10852-10861. PubMed ID: 36338235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality Standards for Surgery of Colorectal Peritoneal Metastasis After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
    García-Fadrique A; Estevan Estevan R; Sabater Ortí L
    Ann Surg Oncol; 2022 Jan; 29(1):188-202. PubMed ID: 34435297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effective Strategies to Predict Survival of Colorectal Peritoneal Metastases Patients Eligible for Cytoreductive Surgery and HIPEC.
    Simkens GA; Wintjens AGWE; Rovers KP; Nienhuijs SW; de Hingh IH
    Cancer Manag Res; 2021; 13():5239-5249. PubMed ID: 34234566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of the ACY-1 gene on HER2 and TRAIL expression in rectal carcinoma.
    Xu Z; Hu Y; Yu Z
    Exp Ther Med; 2021 Aug; 22(2):817. PubMed ID: 34131440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytoreductive surgery and HIPEC for malignant ascites from colorectal cancer - a randomized study.
    Ba M; Chen C; Long H; Gong Y; Wu Y; Lin K; Tu Y; Zhang B; Wu W
    Medicine (Baltimore); 2020 Aug; 99(33):e21546. PubMed ID: 32872001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-analysis of prognostic factors for patients with colorectal peritoneal metastasis undergoing cytoreductive surgery and heated intraperitoneal chemotherapy.
    Hallam S; Tyler R; Price M; Beggs A; Youssef H
    BJS Open; 2019 Oct; 3(5):585-594. PubMed ID: 31592510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pelvic Exenteration with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS + HIPEC) for Rectal Cancer-Case Series with Review of Literature.
    Shinde RS; Acharya R; Kumar NA; Solanki S; Desouza A; Saklani A
    Indian J Surg Oncol; 2019 Feb; 10(Suppl 1):80-83. PubMed ID: 30886498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic Review of Variations in Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Peritoneal Metastasis from Colorectal Cancer.
    Yurttas C; Hoffmann G; Tolios A; Haen SP; Schwab M; Königsrainer I; Königsrainer A; Beckert S; Löffler MW
    J Clin Med; 2018 Dec; 7(12):. PubMed ID: 30572653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.